Search

everythinglearnresearchcommunity

for

Search:↓

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

PCOS and eating disorders are linked by hormonal imbalances, needing personalized treatment.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

The document doesn't provide enough information to summarize.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Classical PCOS types A and B are most common and linked to higher health risks.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.